Our partners Mediphealthwill exhibit and demonstrate Kanteron‘s solutions at Hall 15, booth B01, of Medica2015 trade show which will take place16-19 November in Düsseldorf (Germany).
Medica is the world’s largest event for the medical sector, and has been held for over 40 years.
The Mayor of London Boris Johnson MP travelled to Yokohama (Japan) with representatives from 8 of the most promising BioTech companies in London to promote UK-Japan collaboration in cell therapy and regenerative medicine at the BioJapan 2015. BioJapan is Asia’s leading biotechnology event, attracting thousands of representatives from some 700 of the world’s leading bioscience companies every year. This year it took place October 14th – 16th at Pacifico Yokohama.
Kanteron Systems and Ver2 Digital Medicine introduce the first Medical Imaging and Genomics Data Integration platform in the United Arab Emirates.
Doctors in the Middle East can now examine your symptoms, correlate them with your electronic medical records, medical imaging exams, pathology tests, and your genomic data. Doctors then instantly compare those results with the data on thousands of other individuals to deliver a detailed diagnosis — or even detect an illness before the symptoms appear.
Kanteron Systems has been invited by IBM Spain to participate in the IBM Business Connect, to be held in Madrid (Spain) November 25, 2015.
Click herefor more info.
Together with the Academic Health Science Networks (AHSNs), and HM Government, NHS England has invited Kanteron Systems to the second round of their ‘test bed programme.
The test bed programme is about deploying technologies that are ready to use, in NHS settings—not about inventing new ones.
Kanteron Systems is ready to accept this challenge and deliver what the NHS has described as ‘high value innovation‘.
July 29th, at The Kia Oval, London, Kanteron Systems will meet several NHS sites interested in deploying our solutions.
Dr. Raminder Singh and Santiago Gala join Kanteron’s team.
Dr Raminderpal Singh has joined Kanteron Systems as Strategic Advisor.
Dr. Singh was until now Business Development & Strategy Lead at IBM Research-Genomic Medicine. His experience in Venture Capital at 3i Group, as well as his international experience with healthcare organizations in countries like Singapore, UK, and Canada, and with deals and partnerships in USA, China, India, Russia, and Brazil fit perfectly well with Kanteron’s momentum of explosive international growth and exploration of new partnerships and corporate options.
Tuesday June 2 Kanteron System‘ Alvaro González – CIO and Juan Tatay – COO presented Kanteron Systems‘ experience with IBM at the IBM Cloud event “Dream it! Build it!” in Madrid. #IBMCloudDreamIt
Kanteron‘s success case was presented along two other companies: Evolufarma and SKIOS.
